{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:22:59Z","timestamp":1791433379862,"version":"4.3.3"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, but the molecular mechanisms underlying its course remain incompletely understood. We measured 4789 cerebrospinal fluid proteins in 1040 samples from 438 individuals with MS and controls followed longitudinally. To isolate disease-related biology, we adjusted for normal aging, sex, while also measuring residual effects of demographic and genetic covariates. Here we show that 3714 proteins are significantly associated with twelve clinical and imaging outcomes, highlighting processes linked to viral infection, disruption of epithelial barriers, stromal cell\u2013mediated tissue remodeling, demyelination, and synaptic and neuronal loss. We also find strong sex-related differences: men show greater activation of pathways associated with tissue injury and disability accumulation, whereas women upregulate neurodevelopmental programs that may promote resilience or repair. These molecular maps of MS natural history provide a framework for understanding disease mechanisms and a resource for future drug development.<\/jats:p>","DOI":"10.1038\/s41467-025-65154-8","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:07:28Z","timestamp":1764785248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology"],"prefix":"10.1038","volume":"16","author":[{"given":"Peter","family":"Kosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lumbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Jason","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruturaj","family":"Masvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-9963","authenticated-orcid":false,"given":"Yujin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael","family":"Varosanec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-8417","authenticated-orcid":false,"given":"Lori","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-9430","authenticated-orcid":false,"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"65154_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/1352458519887328","volume":"26","author":"L Amezcua","year":"2020","unstructured":"Amezcua, L. & McCauley, J. L. Race and ethnicity on MS presentation and disease course. Mult. Scler. 26, 561\u2013567 (2020).","journal-title":"Mult. Scler."},{"key":"65154_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves, J. S. et al. Ageing and multiple sclerosis. Lancet Neurol. 22, 66\u201377 (2023).","journal-title":"Lancet Neurol."},{"key":"65154_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1352458519892491","volume":"26","author":"RR Voskuhl","year":"2020","unstructured":"Voskuhl, R. R. The effect of sex on multiple sclerosis risk and disease progression. Mult. Scler. 26, 554\u2013560 (2020).","journal-title":"Mult. Scler."},{"key":"65154_CR4","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. Ther. Adv. Neurol. Disord. 13, 1756286420969016 (2020).","DOI":"10.1177\/1756286420969016"},{"key":"65154_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fneur.2017.00577","volume":"8","author":"AM Weideman","year":"2017","unstructured":"Weideman, A. M., Tapia-Maltos, M. A., Johnson, K., Greenwood, M. & Bielekova, B. Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments. Front. Neurol. 8, 577 (2017).","journal-title":"Front. Neurol."},{"key":"65154_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell, G. R. et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 69, 481\u2013492 (2011).","journal-title":"Ann. Neurol."},{"key":"65154_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ana.22054","volume":"68","author":"G Androdias","year":"2010","unstructured":"Androdias, G. et al. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann. Neurol. 68, 465\u2013476 (2010).","journal-title":"Ann. Neurol."},{"key":"65154_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi, R. et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089\u20131104 (2007).","journal-title":"Brain"},{"key":"65154_CR9","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188\u20132197 (2011).","journal-title":"N. Engl. J. Med."},{"key":"65154_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/brain\/aws012","volume":"135","author":"MT Fischer","year":"2012","unstructured":"Fischer, M. T. et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135, 886\u2013899 (2012).","journal-title":"Brain"},{"key":"65154_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad, D. J. et al. Mitochondrial changes within axons in multiple sclerosis. Brain 132, 1161\u20131174 (2009).","journal-title":"Brain"},{"key":"65154_CR12","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider, L. et al. Oxidative damage in multiple sclerosis lesions. Brain 134, 1914\u20131924 (2011).","journal-title":"Brain"},{"key":"65154_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00415-020-10279-7","volume":"268","author":"CS Simonsen","year":"2021","unstructured":"Simonsen, C. S. et al. The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression. J. Neurol. 268, 1330\u20131341 (2021).","journal-title":"J. Neurol."},{"key":"65154_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamaneurol.2019.0330","volume":"76","author":"O Beiki","year":"2019","unstructured":"Beiki, O., Frumento, P., Bottai, M., Manouchehrinia, A. & Hillert, J. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden. JAMA Neurol. 76, 665\u2013671 (2019).","journal-title":"JAMA Neurol."},{"key":"65154_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta, M. et al. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 597, 709\u2013714 (2021).","journal-title":"Nature"},{"key":"65154_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S Jakel","year":"2019","unstructured":"Jakel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543\u2013547 (2019).","journal-title":"Nature"},{"key":"65154_CR17","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.immuni.2023.04.013","volume":"56","author":"MG Kiss","year":"2023","unstructured":"Kiss, M. G. et al. Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity 56, 1502\u20131514.e1508 (2023).","journal-title":"Immunity"},{"key":"65154_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75\u201382 (2019).","journal-title":"Nature"},{"key":"65154_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","volume":"578","author":"MA Wheeler","year":"2020","unstructured":"Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593\u2013599 (2020).","journal-title":"Nature"},{"key":"65154_CR20","doi-asserted-by":"publisher","first-page":"22932","DOI":"10.1073\/pnas.2008523117","volume":"117","author":"A Ramesh","year":"2020","unstructured":"Ramesh, A. et al. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc. Natl. Acad. Sci. USA 117, 22932\u201322943 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65154_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","volume":"54","author":"M Heming","year":"2021","unstructured":"Heming, M. et al. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity 54, 164\u2013175.e166 (2021).","journal-title":"Immunity"},{"key":"65154_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14118-w","volume":"11","author":"D Schafflick","year":"2020","unstructured":"Schafflick, D. et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat. Commun. 11, 247 (2020).","journal-title":"Nat. Commun."},{"key":"65154_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41590-021-00948-8","volume":"22","author":"M Hiltensperger","year":"2021","unstructured":"Hiltensperger, M. et al. Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity. Nat. Immunol. 22, 880\u2013892 (2021).","journal-title":"Nat. Immunol."},{"key":"65154_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adc9778","volume":"14","author":"P Ostkamp","year":"2022","unstructured":"Ostkamp, P. et al. A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis. Sci. Transl. Med. 14, eadc9778 (2022).","journal-title":"Sci. Transl. Med."},{"key":"65154_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578088","volume":"378","author":"L Muller-Miny","year":"2023","unstructured":"Muller-Miny, L. et al. Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 378, 578088 (2023).","journal-title":"J. Neuroimmunol."},{"key":"65154_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"65154_CR27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk, L. L. & Thorley-Lawson, D. A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79, 1296\u20131307 (2005).","journal-title":"J. Virol."},{"key":"65154_CR28","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1128\/MCB.17.10.5748","volume":"17","author":"L Zhang","year":"1997","unstructured":"Zhang, L. & Pagano, J. S. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell Biol. 17, 5748\u20135757 (1997).","journal-title":"Mol. Cell Biol."},{"key":"65154_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gene.2011.21","volume":"12","author":"S Ning","year":"2011","unstructured":"Ning, S., Pagano, J. S. & Barber, G. N. IRF7: activation, regulation, modification and function. Genes Immun. 12, 399\u2013414 (2011).","journal-title":"Genes Immun."},{"key":"65154_CR30","doi-asserted-by":"publisher","first-page":"e48370","DOI":"10.1371\/journal.pone.0048370","volume":"7","author":"B Bielekova","year":"2012","unstructured":"Bielekova, B., Komori, M., Xu, Q., Reich, D. S. & Wu, T. Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation. PLoS ONE 7, e48370 (2012).","journal-title":"PLoS ONE"},{"key":"65154_CR31","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1212\/WNL.46.6.1626","volume":"46","author":"GA Rosenberg","year":"1996","unstructured":"Rosenberg, G. A., Dencoff, J. E., Correa, N. Jr, Reiners, M. & Ford, C. C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46, 1626\u20131632 (1996).","journal-title":"Neurology"},{"key":"65154_CR32","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","volume":"76","author":"J Kuhle","year":"2011","unstructured":"Kuhle, J. et al. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76, 1206\u20131213 (2011).","journal-title":"Neurology"},{"key":"65154_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","volume":"64","author":"JN Lycke","year":"1998","unstructured":"Lycke, J. N., Karlsson, J. E., Andersen, O. & Rosengren, L. E. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 64, 402\u2013404 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"65154_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101009","volume":"44","author":"M Di Filippo","year":"2024","unstructured":"Di Filippo, M. et al. Fluid biomarkers in multiple sclerosis: from current to future applications. Lancet Reg. Health Eur. 44, 101009 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"65154_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/WNL.51.3.753","volume":"51","author":"K Fassbender","year":"1998","unstructured":"Fassbender, K. et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 51, 753\u2013758 (1998).","journal-title":"Neurology"},{"key":"65154_CR36","first-page":"19","volume":"7","author":"VK Harris","year":"2017","unstructured":"Harris, V. K., Tuddenham, J. F. & Sadiq, S. A. Biomarkers of multiple sclerosis: current findings. Degener. Neurol. Neuromuscul. Dis. 7, 19\u201329 (2017).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"65154_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2019.00338","volume":"10","author":"KN Varhaug","year":"2019","unstructured":"Varhaug, K. N., Torkildsen, O., Myhr, K. M. & Vedeler, C. A. Neurofilament Light Chain as a Biomarker in Multiple Sclerosis. Front Neurol. 10, 338 (2019).","journal-title":"Front Neurol."},{"key":"65154_CR38","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","volume":"53","author":"E Waubant","year":"1999","unstructured":"Waubant, E. et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53, 1397\u20131401 (1999).","journal-title":"Neurology"},{"key":"65154_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2014.03.004","volume":"40","author":"S Angiari","year":"2014","unstructured":"Angiari, S. et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity 40, 542\u2013553 (2014).","journal-title":"Immunity"},{"key":"65154_CR40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","volume":"13","author":"S Amini-Bavil-Olyaee","year":"2013","unstructured":"Amini-Bavil-Olyaee, S. et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13, 452\u2013464 (2013).","journal-title":"Cell Host Microbe"},{"key":"65154_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-immunol-032713-120252","volume":"33","author":"CD Buckley","year":"2015","unstructured":"Buckley, C. D., Barone, F., Nayar, S., Benezech, C. & Caamano, J. Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu. Rev. Immunol. 33, 715\u2013745 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"65154_CR42","doi-asserted-by":"crossref","unstructured":"Leppert D. et al. Blood neurofilament light in progressive multiple sclerosis: post hoc analysis of 2 randomized controlled trials. Neurolgy 98, e2120-e2131 (2022).","DOI":"10.1212\/WNL.0000000000200258"},{"key":"65154_CR43","doi-asserted-by":"publisher","first-page":"649876","DOI":"10.3389\/fnins.2021.649876","volume":"15","author":"R Masvekar","year":"2021","unstructured":"Masvekar, R., Phillips, J., Komori, M., Wu, T. & Bielekova, B. Cerebrospinal fluid biomarkers of myeloid and glial cell activation are correlated with multiple sclerosis lesional inflammatory activity. Front Neurosci. 15, 649876 (2021).","journal-title":"Front Neurosci."},{"key":"65154_CR44","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","volume":"89","author":"L Novakova","year":"2017","unstructured":"Novakova, L. et al. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Neurology 89, 2230\u20132237 (2017).","journal-title":"Neurology"},{"key":"65154_CR45","unstructured":"Fox-Rawlings, S. & Zuckerman, D. NCHR Report: The Health Risks of MRIs with Gadolinium-Based Contrast Agents. (National Center for Health Research, 2019)."},{"key":"65154_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino, F. S. et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 67, 220\u2013229 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"65154_CR47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/09540261.2017.1322555","volume":"29","author":"SB Patten","year":"2017","unstructured":"Patten, S. B., Marrie, R. A. & Carta, M. G. Depression in multiple sclerosis. Int. Rev. Psychiatry 29, 463\u2013472 (2017).","journal-title":"Int. Rev. Psychiatry"},{"key":"65154_CR48","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4049\/jimmunol.1601566","volume":"198","author":"NB Pikor","year":"2017","unstructured":"Pikor, N. B., Cupovic, J., Onder, L., Gommerman, J. L. & Ludewig, B. Stromal Cell Niches in the Inflamed Central Nervous System. J. Immunol. 198, 1775\u20131781 (2017).","journal-title":"J. Immunol."},{"key":"65154_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","volume":"14","author":"BA Heesters","year":"2014","unstructured":"Heesters, B. A., Myers, R. C. & Carroll, M. C. Follicular dendritic cells: dynamic antigen libraries. Nat. Rev. Immunol. 14, 495\u2013504 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"65154_CR50","doi-asserted-by":"publisher","first-page":"1175874","DOI":"10.3389\/fimmu.2023.1175874","volume":"14","author":"N Alvarez-Sanchez","year":"2023","unstructured":"Alvarez-Sanchez, N. & Dunn, S. E. Potential biological contributers to the sex difference in multiple sclerosis progression. Front. Immunol. 14, 1175874 (2023).","journal-title":"Front. Immunol."},{"key":"65154_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fneur.2016.00131","volume":"7","author":"P Kosa","year":"2016","unstructured":"Kosa, P. et al. Development of a sensitive outcome for economical drug screening for progressive multiple sclerosis treatment. Front. Neurol. 7, 131 (2016).","journal-title":"Front. Neurol."},{"key":"65154_CR52","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753\u2013760 (2012).","journal-title":"Nat. Immunol."},{"key":"65154_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ng1004","volume":"32","author":"S Harroch","year":"2002","unstructured":"Harroch, S. et al. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat. Genet. 32, 411\u2013414 (2002).","journal-title":"Nat. Genet."},{"key":"65154_CR54","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1093\/brain\/awv289","volume":"138","author":"MS Natrajan","year":"2015","unstructured":"Natrajan, M. S. et al. Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination. Brain 138, 3581\u20133597 (2015).","journal-title":"Brain"},{"key":"65154_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nn.2702","volume":"14","author":"JK Huang","year":"2011","unstructured":"Huang, J. K. et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 14, 45\u201353 (2011).","journal-title":"Nat. Neurosci."},{"key":"65154_CR56","doi-asserted-by":"crossref","unstructured":"Zhang, D. et al. Spatial transcriptomics and single-nucleus RNA sequencing reveal a transcriptomic atlas of adult human spinal cord. Elife 12(2024).","DOI":"10.7554\/eLife.92046.2"},{"key":"65154_CR57","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","volume":"69","author":"B Serafini","year":"2010","unstructured":"Serafini, B. et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 69, 677\u2013693 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"65154_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani, A., Corboy, J. R., Al-Salam, S. & Khan, G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 13, e0192109 (2018).","journal-title":"PLoS One"},{"key":"65154_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio, A. Environmental factors in multiple sclerosis. Expert Rev. Neurother. 13, 3\u20139 (2013).","journal-title":"Expert Rev. Neurother."},{"key":"65154_CR60","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","volume":"74","author":"SA Sargsyan","year":"2010","unstructured":"Sargsyan, S. A. et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74, 1127\u20131135 (2010).","journal-title":"Neurology"},{"key":"65154_CR61","doi-asserted-by":"crossref","unstructured":"Serafini, B. et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. (2007).","DOI":"10.1084\/jem.20071030"},{"key":"65154_CR62","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1172\/JCI200523661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok, S. et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 115, 1352\u20131360 (2005).","journal-title":"J. Clin. Invest."},{"key":"65154_CR63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00415-009-5296-y","volume":"257","author":"D Pohl","year":"2010","unstructured":"Pohl, D. et al. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J. Neurol. 257, 212\u2013216 (2010).","journal-title":"J. Neurol."},{"key":"65154_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0188-1","volume":"11","author":"M Castellazzi","year":"2014","unstructured":"Castellazzi, M. et al. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. J. Neuroinflamm. 11, 188 (2014).","journal-title":"J. Neuroinflamm."},{"key":"65154_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2015.01.009","volume":"42","author":"A Wieland","year":"2015","unstructured":"Wieland, A. et al. Antibody effector functions mediated by Fcgamma-receptors are compromised during persistent viral infection. Immunity 42, 367\u2013378 (2015).","journal-title":"Immunity"},{"key":"65154_CR66","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.182.5.1213","volume":"182","author":"K Jones","year":"1995","unstructured":"Jones, K. et al. Infection of human endothelial cells with Epstein-Barr virus. J. Exp. Med. 182, 1213\u20131221 (1995).","journal-title":"J. Exp. Med."},{"key":"65154_CR67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","volume":"230","author":"C Casiraghi","year":"2011","unstructured":"Casiraghi, C., Dorovini-Zis, K. & Horwitz, M. S. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J. Neuroimmunol. 230, 173\u2013177 (2011).","journal-title":"J. Neuroimmunol."},{"key":"65154_CR68","doi-asserted-by":"publisher","first-page":"e1006404","DOI":"10.1371\/journal.ppat.1006404","volume":"13","author":"RJ Kraus","year":"2017","unstructured":"Kraus, R. J. et al. Hypoxia-inducible factor-1alpha plays roles in Epstein-Barr virus\u2019s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathog. 13, e1006404 (2017).","journal-title":"PLoS Pathog."},{"key":"65154_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/brain\/awaa427","volume":"144","author":"SK Halder","year":"2021","unstructured":"Halder, S. K. & Milner, R. Hypoxia in multiple sclerosis; is it the chicken or the egg?. Brain 144, 402\u2013410 (2021).","journal-title":"Brain"},{"key":"65154_CR70","doi-asserted-by":"publisher","first-page":"16544","DOI":"10.1073\/pnas.1400818111","volume":"111","author":"RM Temple","year":"2014","unstructured":"Temple, R. M. et al. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc. Natl. Acad. Sci. USA 111, 16544\u201316549 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65154_CR71","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","volume":"49","author":"N Shiee","year":"2010","unstructured":"Shiee, N. et al. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. NeuroImage 49, 1524\u20131535 (2010).","journal-title":"NeuroImage"},{"key":"65154_CR72","doi-asserted-by":"crossref","unstructured":"Kim, Y., Varosanec, M., Kosa, P. & Bielekova, B. Confounder-adjusted MRI-based predictors of multiple sclerosis disability. medRxiv, 2022.2004.2018.22273974 (2022).","DOI":"10.1101\/2022.04.18.22273974"},{"key":"65154_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroimage.2016.10.009","volume":"145","author":"B De Leener","year":"2017","unstructured":"De Leener, B. et al. SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data. NeuroImage 145, 24\u201343 (2017).","journal-title":"NeuroImage"},{"key":"65154_CR74","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/acn3.640","volume":"5","author":"P Kosa","year":"2018","unstructured":"Kosa, P. et al. NeurEx: digitalized neurological examination offers a novel high-resolution disability scale. Ann. Clin. Transl. Neurol. 5, 1241\u20131249 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"65154_CR75","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"65154_CR76","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.34.10.1368","volume":"34","author":"JC Sipe","year":"1984","unstructured":"Sipe, J. C. et al. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 34, 1368\u20131372 (1984).","journal-title":"Neurology"},{"key":"65154_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","volume":"78","author":"M Komori","year":"2015","unstructured":"Komori, M. et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann. Neurol. 78, 3\u201320 (2015).","journal-title":"Ann. Neurol."},{"key":"65154_CR78","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.4049\/jimmunol.1302884","volume":"192","author":"S Han","year":"2014","unstructured":"Han, S. et al. Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases. J. Immunol. 192, 2551\u20132563 (2014).","journal-title":"J. Immunol."},{"key":"65154_CR79","doi-asserted-by":"publisher","first-page":"565957","DOI":"10.3389\/fneur.2020.565957","volume":"11","author":"PA Hannikainen","year":"2020","unstructured":"Hannikainen, P. A., Kosa, P., Barbour, C. & Bielekova, B. Extensive healthy donor age\/gender adjustments and propensity score matching reveal physiology of multiple sclerosis through immunophenotyping. Front. Neurol. 11, 565957 (2020).","journal-title":"Front. Neurol."},{"key":"65154_CR80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","journal-title":"Nature"},{"key":"65154_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13023","volume":"18","author":"P Sebastiani","year":"2019","unstructured":"Sebastiani, P. et al. A serum protein signature of APOE genotypes in centenarians. Aging Cell 18, e13023 (2019).","journal-title":"Aging Cell"},{"key":"65154_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"DE Ho","year":"2011","unstructured":"Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1\u201328 (2011).","journal-title":"J. Stat. Softw."},{"key":"65154_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"65154_CR84","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"65154_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57002-6","volume":"16","author":"F Parween","year":"2025","unstructured":"Parween, F. et al. Migration arrest and transendothelial trafficking of human pathogenic-like Th17 cells are mediated by differentially positioned chemokines. Nat. Commun. 16, 1978 (2025).","journal-title":"Nat. Commun."},{"key":"65154_CR86","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."},{"key":"65154_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29356-8","volume":"13","author":"MP Mule","year":"2022","unstructured":"Mule, M. P., Martins, A. J. & Tsang, J. S. Normalizing and denoising protein expression data from droplet-based single cell profiling. Nat. Commun. 13, 2099 (2022).","journal-title":"Nat. Commun."},{"key":"65154_CR88","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. (Vienna, Austria, 2021)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65154-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:02:59Z","timestamp":1765371779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65154"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65154-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lori Jennings is an employee of Novartis. No other authors declare any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11012"}}